CVS Health Corp
NYSE:CVS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
53.19
81.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
CVS Health Corp
CVS Health Corp
Cash & Cash Equivalents
CVS Health Corp
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CVS Health Corp
NYSE:CVS
|
Cash & Cash Equivalents
$6.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
20%
|
|
|
DaVita Inc
NYSE:DVA
|
Cash & Cash Equivalents
$1.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Chemed Corp
NYSE:CHE
|
Cash & Cash Equivalents
$238.5m
|
CAGR 3-Years
102%
|
CAGR 5-Years
92%
|
CAGR 10-Years
29%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash & Cash Equivalents
$764m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
16%
|
|
|
Cigna Corp
NYSE:CI
|
Cash & Cash Equivalents
$5.9B
|
CAGR 3-Years
19%
|
CAGR 5-Years
5%
|
CAGR 10-Years
14%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash & Cash Equivalents
$1.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
33%
|
CAGR 10-Years
10%
|
|
CVS Health Corp
Glance View
CVS Health Corp. embodies a pivotal role in the evolving healthcare landscape, blending retail pharmacy services with a robust healthcare system. Founded in 1963, CVS has transformed from a traditional pharmacy into a comprehensive health services provider, offering a myriad of solutions including pharmacy benefit management, retail clinics, and specialized health programs. The company’s strategic acquisitions, notably the purchase of Aetna in 2018, have positioned CVS to deliver integrated healthcare solutions that not only enhance patient care but also streamline costs. This diversified business model is designed to meet the growing demand for accessible and affordable healthcare, enabling CVS to capture a substantial share of the market while driving sustainable revenue growth. For investors, CVS Health represents an enticing opportunity, rooted in its fundamental strengths and forward-looking strategies. The company's ability to adapt to changing healthcare trends, such as the rise of telehealth and the increasing importance of preventative care, underscores its commitment to innovation. With a significant foothold in both retail and insurance sectors, CVS is uniquely positioned to capitalize on synergies that enhance profitability and customer satisfaction. Additionally, the company’s consistent focus on expense management and strategic investments in digital health technologies promise to fortify its competitive edge. As CVS Health continues to expand its services and improve operational efficiencies, investors can anticipate a resilient performance, making it a compelling consideration for those looking to invest in the future of healthcare.
See Also
What is CVS Health Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
6.9B
USD
Based on the financial report for Sep 30, 2024, CVS Health Corp's Cash & Cash Equivalents amounts to 6.9B USD.
What is CVS Health Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
20%
Over the last year, the Cash & Cash Equivalents growth was -47%. The average annual Cash & Cash Equivalents growth rates for CVS Health Corp have been -11% over the past three years , 6% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
